Curevo Vaccine

Curevo’s shingles vaccine equals GSK’s Shingrix in phase 2 head-to-head
Fierce Biotech
Tue, 01/9/24 - 09:47 am
Curevo Vaccine
GSK
shingles
vaccines
Shingrix
Curevo Vaccine announces closing of $26m Series A1 round
Pharmaceutical Business Review
Thu, 11/17/22 - 10:34 am
Curevo Vaccine
funding
vaccines
CRV-101
shingles
Vaccines upstart Curevo has designs on blockbuster GSK franchise
Pharmaforum
Mon, 02/14/22 - 10:45 am
Curevo Vaccine
vaccines
GSK
CRV-101
Shingrix
shingles
A small Seattle biotech wants to take on GlaxoSmithKline's emerging Shingrix blockbuster. RA Capital is on board
Endpoints
Thu, 02/10/22 - 10:27 am
GSK
Shingrix
FDA
RA Capital
Curevo Vaccine